Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors Publisher Pubmed



Karami Fath M1 ; Moayedi Banan Z2 ; Barati R3 ; Mohammadrezakhani O4 ; Ghaderi A5 ; Hatami A6 ; Ghiabi S7 ; Zeidi N8 ; Asgari K9 ; Payandeh Z10 ; Barati G11
Authors

Source: Progress in Biophysics and Molecular Biology Published:2023


Abstract

Mesenchymal stem cells (MSCs) have the ability to migrate into tumor sites and release growth factors to modulate the tumor microenvironment. MSC therapy have shown a dual role in cancers, promoting or inhibiting. However, MSCs could be used as a carrier of anticancer agents for targeted tumor therapy. Recent technical improvements also allow engineering MSCs to improve tumor-targeting properties, protect anticancer agents, and decrease the cytotoxicity of drugs. While some of MSC functions are mediated through their secretome, MSCs-derived extracellular vesicles (EVs) are also proposed as a possible viechle for cancer therapy. EVs allow efficient loading of anticancer agents and have an intrinsic ability to target tumor cells, making them suitable for targeted therapy of tumors. In addition, the specificity and selectivity of EVs to the tumor sites could be enhanced by surface modification. In this review, we addressed the current approaches used for engineering MSCs and EVs to effectively target tumor sites and deliver anticancer agents. © 2023 Elsevier Ltd
Related Docs
View other Related Docs
1. The Therapeutic Effect of Mscs and Their Extracellular Vesicles on Neuroblastoma, Progress in Biophysics and Molecular Biology (2024)
2. Mesenchymal Stem Cell-Released Oncolytic Virus: An Innovative Strategy for Cancer Treatment, Cell Communication and Signaling (2023)
3. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
Experts (# of related papers)
View all Related Experts
Rasoul Salehi (6)
Shaghayegh Haghjooy Javanmard (5)
Other Related Docs
4. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
5. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
6. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
7. Msc-Derived Exosomes Enhance the Anticancer Activity of Drugs in 3D Spheroid of Breast Cancer Cells, Journal of Drug Delivery Science and Technology (2024)
8. Emerging Role of Mesenchymal Stem/Stromal Cells (Mscs) and Mscs-Derived Exosomes in Bone- and Joint-Associated Musculoskeletal Disorders: A New Frontier, European Journal of Medical Research (2023)
9. Oncolytic Newcastle Disease Virus Delivered by Mesenchymal Stem Cells-Engineered System Enhances the Therapeutic Effects Altering Tumor Microenvironment, Virology Journal (2020)
10. Therapeutic Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles’ Mirnas on Retinal Regeneration: A Review, Stem Cell Research and Therapy (2021)
11. The Role of Mirnas From Mesenchymal Stem/Stromal Cells-Derived Extracellular Vesicles in Neurological Disorders, Human Cell (2023)
12. Human Wharton's Jelly Mesenchymal Stem Cells-Derived Secretome Could Inhibit Breast Cancer Growth in Vitro and in Vivo, Iranian Journal of Basic Medical Sciences (2020)
13. An Anticancer Effect of Umbilical Cord-Derived Mesenchymal Stem Cell Secretome on the Breast Cancer Cell Line, Cell and Tissue Banking (2019)
14. Microrna-100 Shuttled by Mesenchymal Stem Cell-Derived Exosomes Suppresses in Vitro Angiogenesis Through Modulating the Mtor/Hif-1Α/Vegf Signaling Axis in Breast Cancer Cells, Cellular Oncology (2017)
15. Pathological Role of Inflammation in Ocular Disease Progress and Its Targeting by Mesenchymal Stem Cells (Mscs) and Their Exosome; Current Status and Prospect, Pathology Research and Practice (2023)
16. Roles of Mesenchymal Stem Cells in Breast Cancer Therapy: Engineered Stem Cells and Exosomal Cell-Free Based Therapy, Current Molecular Medicine (2025)
17. Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination With Chemotherapy/Radiotherapy for Cancer Patients, Critical Reviews in Eukaryotic Gene Expression (2015)
18. Phic31/Piggybac Modified Stromal Stem Cells: Effect of Interferon Γ And/Or Tumor Necrosis Factor (Tnf)-Related Apoptosis-Inducing Ligand (Trail) on Murine Melanoma, Molecular Cancer (2014)
19. Early Diagnosis of Breast and Ovarian Cancers by Body Fluids Circulating Tumor-Derived Exosomes, Cancer Cell International (2020)
20. Genetically Modified Murine Adipose-Derived Mesenchymal Stem Cells Producing Interleukin-2 Favor B16f10 Melanoma Cell Proliferation, Immunological Investigations (2015)